Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Protagenic Therapeutics, Inc. - Warrant
No Price
13.04.2026 19:56
Current Prices from Protagenic Therapeutics, Inc. - Warrant
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
PTIXW
USD
13.04.2026 19:56
0,004 USD
-
Share Float & Liquidity
Free Float101,71 %
Shares Float1,84 M
Shares Outstanding1,81 M
Company Profile for Protagenic Therapeutics, Inc. - Warrant Share
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.
